Measles vaccination rates in central Ohio remained significantly below the threshold needed for herd immunity nearly two years after a major outbreak in the region, according to data presented at the Pediatric Academic Societies annual meeting in Boston. The findings underscore persistent challenges in sustaining immunization coverage even after outbreak containment efforts have concluded.
Rosemary A. Martoma, MD, MBChB, a fellow in general academic pediatrics and the computational health informatics program at Boston Children’s Hospital and Harvard Medical School, emphasized that while outbreak response can successfully interrupt transmission in the short term, achieving lasting improvements in vaccination rates demands sustained, long-term public health engagement. She highlighted the importance of real-time surveillance systems and robust primary care infrastructure in preventing future resurgences.
The study, which analyzed post-outbreak immunization trends, revealed that measles vaccine coverage in the affected communities failed to rebound to levels sufficient to prevent renewed transmission. Herd immunity for measles typically requires approximately 95% coverage with two doses of the measles-mumps-rubella (MMR) vaccine due to the virus’s high contagiousness. Despite intensive outbreak response efforts in 2022, vaccination rates in central Ohio remained notably below this benchmark through at least late 2024.
These results align with broader concerns about the fragility of measles elimination status in the United States, where declining vaccination confidence and access barriers have contributed to localized gaps in immunity. Public health officials warn that without targeted, community-based interventions to address vaccine hesitancy and improve access, similar outbreaks could recur.
Understanding Herd Immunity and Measles Transmission
Herd immunity occurs when a sufficient proportion of a population is immune to an infectious disease, thereby providing indirect protection to those who are not immune. For measles, one of the most contagious viruses known to infect humans, this threshold is exceptionally high—estimated at 93% to 95% population immunity—because each infected person can transmit the virus to 12 to 18 others in a fully susceptible setting.
The MMR vaccine, administered in two doses, is highly effective, with about 97% effectiveness after two doses. However, even small declines in coverage can erode community protection, particularly in close-knit or under-vaccinated communities where exposure risks are amplified.
Ohio Outbreak Context and Response
The central Ohio measles outbreak began in late 2021 and peaked in early 2022, primarily affecting unvaccinated children in several counties. Over 80 cases were confirmed during the outbreak, with most occurring among individuals who had not received any doses of the MMR vaccine. Public health agencies launched aggressive containment measures, including isolation protocols, contact tracing and targeted vaccination clinics.
While these interventions successfully curtailed further spread by mid-2022, the latest data indicate that routine immunization rates did not recover to pre-outbreak levels in the following months. This gap raises concerns about long-term vulnerability, especially as international travel increases the risk of imported cases from regions where measles remains endemic.
Implications for Public Health Policy
Experts stress that outbreak response alone is insufficient to ensure lasting protection. Sustainable improvements in vaccination coverage require ongoing investment in vaccine education, equitable access to immunization services, and trust-building initiatives within communities. Strengthening school immunization requirements, expanding reminder-recall systems, and leveraging electronic health records to identify under-vaccinated populations are among the strategies recommended to close immunity gaps.
integrating immunization status checks into routine pediatric visits and expanding outreach through faith-based organizations, schools, and local leaders can facilitate reach hesitant or hard-to-reach families. Surveillance systems capable of detecting early declines in vaccination rates may also enable faster public health responses before outbreaks occur.
National Trends in Measles Immunity
National data from the Centers for Disease Control and Prevention (CDC) show that while overall MMR coverage in the United States remains high, pockets of low vaccination persist. Kindergarten MMR coverage dipped below 95% nationally during the 2020–2021 school year and has not fully recovered, with exemptions for non-medical reasons increasing in several states.
These trends have prompted renewed attention to state-level immunization policies and the role of healthcare providers in vaccine counseling. The American Academy of Pediatrics continues to advocate for timely routine vaccination and opposes non-medical exemptions to school immunization requirements.
As of now, no modern measles cases linked to the original Ohio outbreak have been reported in 2025. The next scheduled update on state-specific immunization coverage will arrive from the CDC’s annual school vaccination report, expected in late 2025. Readers are encouraged to consult their healthcare providers about vaccination status and to refer to official CDC guidelines for the most current measles prevention recommendations.
We welcome your thoughts and experiences regarding vaccination access and public health communication in your community. Please share your insights in the comments below or join the conversation on social media using #VaccinationMatters.